Treatment success rate for patients treated for MDR-TB in Switzerland
Switzerland: Treatment success rate for patients treated for MDR-TB was 60.0% in 2022. ▼ Falling
Latest (2022)
60.0%
World rank
120th
of 163 countries
All-time high
100.0%
in 2020
All-time low
0.0%
in 2021
Years of data
9
2014–2022
Treatment success rate for patients treated for MDR-TB in Switzerland, 2014–2022
Source: World Health Organization, Global Health Observatory.
Analysis
Switzerland recorded 60.0% for treatment success rate for patients treated for mdr-tb in 2022.
That represents a change of down 20.0% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Switzerland peaked at 100.0% in 2020 and was at its lowest, 0.0%, in 2021.
Switzerland ranks 120th of 163 countries on this measure, in the middle of the range.
Treatment success rate for patients treated for MDR-TB in Switzerland, year by year
| Year | Value | Change |
|---|---|---|
| 2014 | 75.0% | — |
| 2015 | 44.0% | -41.3% |
| 2016 | 47.0% | +6.8% |
| 2017 | 83.0% | +76.6% |
| 2018 | 67.0% | -19.3% |
| 2019 | 92.0% | +37.3% |
| 2020 | 100.0% | +8.7% |
| 2021 | 0.0% | -100.0% |
| 2022 | 60.0% | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 68.0% | 44.0% | 92.0% | 6 |
| 2020s | 53.3% | 0.0% | 100.0% | 3 |
Countries ranked near Switzerland
More health data for Switzerland
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.27 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,104 deaths per 1,000 people (2090)
- Number of infants who die before age 1 46 deaths (2100)
- Population ages 30-34, female, annual growth rate -2.29 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0327 units per person (2025)
- Population ages 30-34, male, annual growth rate -2.04 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0338 units per person (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Switzerland?
- Treatment success rate for patients treated for mdr-tb in Switzerland was 60.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Switzerland?
- The highest recorded value was 100.0% in 2020.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Switzerland?
- The lowest recorded value was 0.0% in 2021.
- How does Switzerland rank for treatment success rate for patients treated for mdr-tb?
- Switzerland ranks 120th out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Switzerland?
- Over the last ten years it is down 20.0%. The long-run trend across the full record is falling.
- Where does this Switzerland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).